Supply Chain

The Trump administration's decision to impose a 25% tariff on all steel and aluminum imports is expected to impact the medical device industry. 

Here are eight new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

Forbes named 21 healthcare suppliers, devicemakers and life sciences companies among its list of America's best large employers for 2025, released Feb. 13.

Sentec and Percussionaire have recalled their VDR4 Phasitron Breathing Circuit Kits due to a venturi component malfunction that may reduce pressure and airflow, potentially leading to serious injury or death. 

Medline has been awarded a vendor contract by the Department of Veterans Affairs. 

The FDA issued a warning regarding the Rotarex Atherectomy System, a device used to break up and remove the thrombus from peripheral arteries. 

Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks. 

The American Hospital Association has called on the Trump administration to grant exceptions to proposed tariffs on medical devices and pharmaceuticals sourced from Mexico, Canada and China. 

Thermo Fisher Scientific is eliminating 300 jobs at its Cambridge and Plainville locations, effective March 30. The Waltham-based life sciences firm cited shifts in customer timelines and utilization needs as reasons for the layoffs, The Boston Globe reported Feb. 3. 

The recent imposition of a 10% tariff on Chinese imports is expected to raise the cost of generic drugs in the U.S. and worsen ongoing drug shortages, NBC News reported Feb. 3.